Fundamental Analysis of ATAI LIFE SCIENCES NV(NASDAQ:ATAI) stock

Fundamental Rating

Taking everything into account, ATAI scores 3 out of 10 in our fundamental rating. ATAI was compared to 198 industry peers in the Pharmaceuticals industry. The financial health of ATAI is average, but there are quite some concerns on its profitability. ATAI is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ATAI had negative earnings in the past year.

In the past year ATAI has reported a negative cash flow from operations.

In the past 5 years ATAI always reported negative net income.

In the past 5 years ATAI always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of ATAI (-13.71%) is better than 69.74% of its industry peers.

The Return On Equity of ATAI (-16.56%) is better than 76.41% of its industry peers.

		Industry Rank	Sector Rank
ROA	-13.71%
ROE	-16.56%
ROIC	N/A

ROA(3y)-34.71%

ROA(5y)-55.84%

ROE(3y)-39.84%

ROE(5y)-66.13%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATAI so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ATAI does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ATAI has about the same amount of shares outstanding.

ATAI has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.54, we must say that ATAI is in the distress zone and has some risk of bankruptcy.

ATAI has a Altman-Z score (0.54) which is in line with its industry peers.

A Debt/Equity ratio of 0.07 indicates that ATAI is not too dependend on debt financing.

With a Debt to Equity ratio value of 0.07, ATAI perfoms like the industry average, outperforming 49.74% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	N/A
Altman-Z	0.54

ROIC/WACCN/A

WACC7.09%

2.3 Liquidity

A Current Ratio of 9.22 indicates that ATAI has no problem at all paying its short term obligations.

The Current ratio of ATAI (9.22) is better than 85.64% of its industry peers.

A Quick Ratio of 9.22 indicates that ATAI has no problem at all paying its short term obligations.

The Quick ratio of ATAI (9.22) is better than 85.64% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	9.22
Quick Ratio	9.22

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ATAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.41%, which is quite impressive.

Looking at the last year, ATAI shows a very strong growth in Revenue. The Revenue has grown by 38.26%.

EPS 1Y (TTM)70.41%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q57.14%

Revenue 1Y (TTM)38.26%

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2Q-55%

3.2 Future

ATAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.37% yearly.

Based on estimates for the next years, ATAI will show a very strong growth in Revenue. The Revenue will grow by 342.62% on average per year.

EPS Next Y-162.62%

EPS Next 2Y-57.47%

EPS Next 3Y-30.14%

EPS Next 5Y66.37%

Revenue Next Year-34.07%

Revenue Next 2Y437.64%

Revenue Next 3Y366.95%

Revenue Next 5Y342.62%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ATAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ATAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ATAI's earnings are expected to decrease with -30.14% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-57.47%

EPS Next 3Y-30.14%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ATAI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ATAI LIFE SCIENCES NV

NASDAQ:ATAI (5/1/2024, 7:00:01 PM)

After market: 2.01 -0.04 (-1.95%)

2.05

+0.07 (+3.54%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap340.36M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-13.71%
ROE	-16.56%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	9.22
Quick Ratio	9.22
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)70.41%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-162.62%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)38.26%

Revenue growth 3YN/A

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

ATAI LIFE SCIENCES NV (ATAI)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens